Systematic review of fluorescence-guided surgery in pituitary neuroendocrine tumours.

ABSTRACT:

Objective

Fluorescence-guided surgery represents a potential novel technique to improve the extent of tumour resection, minimise resection of normal tissue, and optimise outcomes in pituitary neuroendocrine tumour surgery. We systematically reviewed the available evidence on this topic to define the current role for fluorescence-guided surgery in this setting.

Design and methods

A systematic review was conducted in accordance with the PRISMA 2020 guidelines. MEDLINE, EMBASE, and the Cochrane Library were searched on 1st March 2025 for studies investigating the use of exogenous fluorophores or autofluorescence in pituitary surgery. Two authors independently screened studies and extracted data from included studies. Risk of bias assessment was performed using the Newcastle-Ott

SUBMITTER: Ovenden CD 

PROVIDER: S-EPMC12495904 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature